CXXIF
Price
$0.31
Change
-$0.09 (-22.50%)
Updated
Sep 25 closing price
Capitalization
66.08M
HKMPY
Price
$43.05
Change
-$1.12 (-2.54%)
Updated
Sep 25 closing price
Capitalization
4.83B
Interact to see
Advertisement

CXXIF vs HKMPY

Header iconCXXIF vs HKMPY Comparison
Open Charts CXXIF vs HKMPYBanner chart's image
C21 Investments
Price$0.31
Change-$0.09 (-22.50%)
Volume$84.21K
Capitalization66.08M
Hikma Pharmaceuticals
Price$43.05
Change-$1.12 (-2.54%)
Volume$2.56K
Capitalization4.83B
CXXIF vs HKMPY Comparison Chart in %
Loading...
CXXIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HKMPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CXXIF vs. HKMPY commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CXXIF is a Hold and HKMPY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (CXXIF: $0.31 vs. HKMPY: $43.05)
Brand notoriety: CXXIF and HKMPY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CXXIF: 11% vs. HKMPY: 114%
Market capitalization -- CXXIF: $66.08M vs. HKMPY: $4.83B
CXXIF [@Pharmaceuticals: Generic] is valued at $66.08M. HKMPY’s [@Pharmaceuticals: Generic] market capitalization is $4.83B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CXXIF’s FA Score shows that 1 FA rating(s) are green whileHKMPY’s FA Score has 1 green FA rating(s).

  • CXXIF’s FA Score: 1 green, 4 red.
  • HKMPY’s FA Score: 1 green, 4 red.
According to our system of comparison, CXXIF is a better buy in the long-term than HKMPY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CXXIF’s TA Score shows that 3 TA indicator(s) are bullish while HKMPY’s TA Score has 3 bullish TA indicator(s).

  • CXXIF’s TA Score: 3 bullish, 6 bearish.
  • HKMPY’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, HKMPY is a better buy in the short-term than CXXIF.

Price Growth

CXXIF (@Pharmaceuticals: Generic) experienced а -10.29% price change this week, while HKMPY (@Pharmaceuticals: Generic) price change was -2.95% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.88%. For the same industry, the average monthly price growth was +23.85%, and the average quarterly price growth was +67.10%.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.88% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HKMPY($4.83B) has a higher market cap than CXXIF($66.1M). CXXIF YTD gains are higher at: 56.900 vs. HKMPY (-11.035). HKMPY has higher annual earnings (EBITDA): 734M vs. CXXIF (4.72M). HKMPY has more cash in the bank: 236M vs. CXXIF (2.66M). CXXIF has less debt than HKMPY: CXXIF (12.9M) vs HKMPY (1.56B). HKMPY has higher revenues than CXXIF: HKMPY (3.22B) vs CXXIF (32.1M).
CXXIFHKMPYCXXIF / HKMPY
Capitalization66.1M4.83B1%
EBITDA4.72M734M1%
Gain YTD56.900-11.035-516%
P/E RatioN/A12.89-
Revenue32.1M3.22B1%
Total Cash2.66M236M1%
Total Debt12.9M1.56B1%
FUNDAMENTALS RATINGS
CXXIF vs HKMPY: Fundamental Ratings
CXXIF
HKMPY
OUTLOOK RATING
1..100
556
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
7
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9579
PRICE GROWTH RATING
1..100
3683
P/E GROWTH RATING
1..100
696
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HKMPY's Valuation (7) in the null industry is significantly better than the same rating for CXXIF (98). This means that HKMPY’s stock grew significantly faster than CXXIF’s over the last 12 months.

HKMPY's Profit vs Risk Rating (100) in the null industry is in the same range as CXXIF (100). This means that HKMPY’s stock grew similarly to CXXIF’s over the last 12 months.

HKMPY's SMR Rating (79) in the null industry is in the same range as CXXIF (95). This means that HKMPY’s stock grew similarly to CXXIF’s over the last 12 months.

CXXIF's Price Growth Rating (36) in the null industry is somewhat better than the same rating for HKMPY (83). This means that CXXIF’s stock grew somewhat faster than HKMPY’s over the last 12 months.

CXXIF's P/E Growth Rating (6) in the null industry is significantly better than the same rating for HKMPY (96). This means that CXXIF’s stock grew significantly faster than HKMPY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CXXIFHKMPY
RSI
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
69%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
49%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
55%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
55%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
60%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
59%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 1 day ago
64%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
55%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
CXXIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HKMPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCMCX30.11N/A
N/A
Goldman Sachs Mid Cap Value C
TMVAX29.08N/A
N/A
RBC Microcap Value A
VAPPX23.28N/A
N/A
VALIC Company I Capital Appreciation
FRVLX58.47N/A
N/A
Franklin Small Cap Value A
RIDGX27.30-0.11
-0.40%
American Funds Income Fund of Amer R6

CXXIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CXXIF has been loosely correlated with GTBIF. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CXXIF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CXXIF
1D Price
Change %
CXXIF100%
-20.56%
GTBIF - CXXIF
54%
Loosely correlated
-7.42%
TCNNF - CXXIF
53%
Loosely correlated
-7.20%
VRNOF - CXXIF
52%
Loosely correlated
-7.20%
TSNDF - CXXIF
52%
Loosely correlated
-12.47%
JUSHF - CXXIF
47%
Loosely correlated
-13.74%
More

HKMPY and

Correlation & Price change

A.I.dvisor tells us that HKMPY and HROW have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HKMPY and HROW's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HKMPY
1D Price
Change %
HKMPY100%
-2.55%
HROW - HKMPY
23%
Poorly correlated
-3.61%
CXXIF - HKMPY
22%
Poorly correlated
-20.56%
HYPMY - HKMPY
14%
Poorly correlated
-1.12%
ETST - HKMPY
10%
Poorly correlated
N/A
INDV - HKMPY
8%
Poorly correlated
-0.18%
More